The data demonstrate that HU308 has a significant therapeutic effect on DSS-induced colitis in mice, as evidenced by the restoration of colon length, reduction in MPO activity in both the colon and spleen, normalization of plasma GLP-1 levels, and reduction in spleen/body weight ratio. The gene discussed is MPO; the disease is colitis.